Pre-transplant management of co-existing diseases

M. Carby

Source: Eur Respir Mon; 2009: 45: 54–61
Journal Issue: Lung Transplantation

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Carby. Pre-transplant management of co-existing diseases. Eur Respir Mon; 2009: 45: 54–61

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary complications in patients with hematologic diseases
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders
Source: Eur Respir Monogr 2019; 86: 1-13
Year: 2019


Coexistence of cardiovascular diseases in patients with COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Pulmonary involvement in rheumatological diseases in children
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Lymphoproliferative disease: prevention and management
Source: School Course 2012 - Lung Transplantation
Year: 2012


Prevalence of undiagnosed COPD in patients with established cardiovascular diseases
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


Severe pulmonary infections due to biological therapy of rheumatic diseases
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011


The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Prevalence and underlying risk factors of clinically undiagnosed obstructive lung disease in internal medicine wards
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Clinical profile of chronic obstructive pulmonary diseases in primary health care
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


A study of hematologic disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Screening for malnutrition in outpatients with pulmonary diseases
Source: Annual Congress 2011 - COPD management
Year: 2011


Candidosis due to treatment pulmonary diseases
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011